These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20304456)

  • 21. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.
    Qiu X; Alimonti JB; Melito PL; Fernando L; Ströher U; Jones SM
    Clin Immunol; 2011 Nov; 141(2):218-27. PubMed ID: 21925951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.
    Bornholdt ZA; Ndungo E; Fusco ML; Bale S; Flyak AI; Crowe JE; Chandran K; Saphire EO
    mBio; 2016 Feb; 7(1):e02154-15. PubMed ID: 26908579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
    Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
    J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu).
    Sobarzo A; Groseth A; Dolnik O; Becker S; Lutwama JJ; Perelman E; Yavelsky V; Muhammad M; Kuehne AI; Marks RS; Dye JM; Lobel L
    J Infect Dis; 2013 Jul; 208(2):299-309. PubMed ID: 23585686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macaque antibodies targeting Marburg virus glycoprotein induced by multivalent immunization.
    Janus BM; Wang R; Cleveland TE; Metcalf MC; Lemmer AC; van Dyk N; Jeong S; Astavans A; Class K; Fuerst TR; Ofek G
    J Virol; 2024 Jul; 98(7):e0015524. PubMed ID: 38832790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitopes involved in antibody-mediated protection from Ebola virus.
    Wilson JA; Hevey M; Bakken R; Guest S; Bray M; Schmaljohn AL; Hart MK
    Science; 2000 Mar; 287(5458):1664-6. PubMed ID: 10698744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.
    Ilinykh PA; Shen X; Flyak AI; Kuzmina N; Ksiazek TG; Crowe JE; Bukreyev A
    J Virol; 2016 Apr; 90(8):3890-3901. PubMed ID: 26819310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines.
    Dowling W; Thompson E; Badger C; Mellquist JL; Garrison AR; Smith JM; Paragas J; Hogan RJ; Schmaljohn C
    J Virol; 2007 Feb; 81(4):1821-37. PubMed ID: 17151111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus.
    Audet J; Wong G; Wang H; Lu G; Gao GF; Kobinger G; Qiu X
    Sci Rep; 2014 Nov; 4():6881. PubMed ID: 25375093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
    Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
    J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors.
    Fan P; Chi X; Liu G; Zhang G; Chen Z; Liu Y; Fang T; Li J; Banadyga L; He S; Yu C; Qiu X; Chen W
    MAbs; 2020; 12(1):1742457. PubMed ID: 32213108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein.
    Zhong L; Haynes L; Struble EB; Tamin A; Virata-Theimer ML; Zhang P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):1056-60. PubMed ID: 19861118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis of broad ebolavirus neutralization by a human survivor antibody.
    West BR; Wec AZ; Moyer CL; Fusco ML; Ilinykh PA; Huang K; Wirchnianski AS; James RM; Herbert AS; Hui S; Goodwin E; Howell KA; Kailasan S; Aman MJ; Walker LM; Dye JM; Bukreyev A; Chandran K; Saphire EO
    Nat Struct Mol Biol; 2019 Mar; 26(3):204-212. PubMed ID: 30833785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus.
    Thomas M; Kropff B; Schneider A; Winkler TH; Görzer I; Sticht H; Britt WJ; Mach M; Reuter N
    J Virol; 2021 Aug; 95(18):e0065721. PubMed ID: 34160252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of two GP-specific monoclonal antibodies, which synergistically protect non-human primates against Ebola lethal infection.
    Shcheblyakov D; Esmagambetov I; Simakin P; Kostina L; Kozlov A; Tsibezov V; Grebennikova T; Chifanov D; Rumyantseva I; Boyarskaya N; Sizikova T; Shagarova N; Andrus А; Shatohina I; Syromyatnikova S; Kovalchuk A; Pantyukhov V; Borisevich S; Zubkova O; Tukhvatulin A; Logunov D; Naroditsky B; Gintsburg A
    Antiviral Res; 2019 Dec; 172():104617. PubMed ID: 31593751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual monoclonal antibody-based sandwich ELISA for detection of in vitro packaged Ebola virus.
    Zai J; Yi K; Xie L; Zhu J; Feng X; Li Y
    Diagn Pathol; 2018 Dec; 13(1):96. PubMed ID: 30567559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2.
    Lennemann NJ; Walkner M; Berkebile AR; Patel N; Maury W
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S204-9. PubMed ID: 26038399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies.
    Murin CD; Gilchuk P; Ilinykh PA; Huang K; Kuzmina N; Shen X; Bruhn JF; Bryan AL; Davidson E; Doranz BJ; Williamson LE; Copps J; Alkutkar T; Flyak AI; Bukreyev A; Crowe JE; Ward AB
    Cell Rep; 2021 Apr; 35(2):108984. PubMed ID: 33852862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.
    Smith SA; de Alwis AR; Kose N; Harris E; Ibarra KD; Kahle KM; Pfaff JM; Xiang X; Doranz BJ; de Silva AM; Austin SK; Sukupolvi-Petty S; Diamond MS; Crowe JE
    mBio; 2013 Nov; 4(6):e00873-13. PubMed ID: 24255124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it.
    Lee JE; Saphire EO
    Curr Opin Struct Biol; 2009 Aug; 19(4):408-17. PubMed ID: 19559599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.